유창훈 조교수
#간암#담도암#췌장암#신경내분비종양#원발미상암
|
학력
2015 .03 ~ 2019 .02울산대학교 의학 박사
2009 .03 ~ 2011 .02울산대학교 의학 석사
2000 .03 ~ 2006 .02울산대학교 의학 학사
2009 .03 ~ 2011 .02울산대학교 의학 석사
2000 .03 ~ 2006 .02울산대학교 의학 학사
경력
2016 .03 ~ 현재서울아산병원 종양내과 조교수
2014 .05 ~ 2016 .02서울아산병원 종양내과 전임의
2012 .04 ~ 2014 .04기무사령부 의무대 내과 과장
2011 .03 ~ 2012 .041 포병여단 내과 군의관
2007 .03 ~ 2011 .02서울아산병원 내과 전공의
2006 .03 ~ 2007 .02서울아산병원 수련의
2014 .05 ~ 2016 .02서울아산병원 종양내과 전임의
2012 .04 ~ 2014 .04기무사령부 의무대 내과 과장
2011 .03 ~ 2012 .041 포병여단 내과 군의관
2007 .03 ~ 2011 .02서울아산병원 내과 전공의
2006 .03 ~ 2007 .02서울아산병원 수련의
논문
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer.
Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor.
Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen
Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients.
Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors.
Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.
Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma.
Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin.
Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology.
Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.
Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients.
Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-containing Regimen.
Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT).
Prognostic signifiance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.
Companion diagnostics for the targeted therapy of gastric cancer
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).
Intraoperatively Assessed Macroscopic Serosal Changes in Patients with Curatively Resected Advanced Gastric Cancer: Clinical Implications for Prognosis and Peritoneal Recurrence
Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer
Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor.
Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen
Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients.
Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors.
Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.
Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma.
Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin.
Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology.
Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.
Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients.
Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-containing Regimen.
Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT).
Prognostic signifiance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.
Companion diagnostics for the targeted therapy of gastric cancer
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).
Intraoperatively Assessed Macroscopic Serosal Changes in Patients with Curatively Resected Advanced Gastric Cancer: Clinical Implications for Prognosis and Peritoneal Recurrence
Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer
저서
저서 내용이 없습니다.
보도자료
서울아산, 담도암 신약 표적치료제 활용 가능성 확대
http://www.dailymedi.com/detail.php?number=850685&thread=22r03
"간암 치료제 '스티바가', 뚜껑 열어보니 기대 이상"
http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058915
암환자들 "미친척하고 샀다"… '강아지 구충제' 품절사태
https://news.mt.co.kr/mtview.php?no=2019092614305043400
http://www.dailymedi.com/detail.php?number=850685&thread=22r03
"간암 치료제 '스티바가', 뚜껑 열어보니 기대 이상"
http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058915
암환자들 "미친척하고 샀다"… '강아지 구충제' 품절사태
https://news.mt.co.kr/mtview.php?no=2019092614305043400
포스팅
Evaluation of genetic mutations and copy number alterations in biliary tract cancer using targeted exome sequencing
Phase 2 study of triplet chemotherapy with oxaliplatin, irinotecan and S-1 (OIS) as first-line treatment in patients with advanced biliary tract cancer (BTC)
Prognostic implications of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin
FcrR3A-158 polymorphism and stromal tumor-infiltrating lymphocytes as predictive markers for trastuzumab-based treatment in patients with metastatic HER2-positive breast cancer
Prognostic implications of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma treated with first-line gemcitabine / cisplatin
# 357 Clinical Benefit of Maintenance Therapy for Patients with Advanced Biliary Tract Cancer without
Progression on First-Line Gemcitabine plus Cisplatin
Multiplexed gene expression profiling of resected intrahepatic cholangiocarcinoma: Implication of FGFR4-FGF19 as a novel treatment target
Efficacy and Safety of Targeted agents for Treatment of Gastroenteropancreatic (GEP) Neuroendocrine tumor (NET): Single Center Experience
Efficacy of Chemotherapy in Patients with Pancreatic Acinar Cell Carcinoma
Clinical outcomes of patients with pancreatic neuroendocrine tumors treated with targeted agents: single center experience
Predictive role of stromal tumor infiltrating lymphocytes (TILs) in patients with metastatic HER2-positive breast cancer (BC) treated with trastuzumab
Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in patients with advanced gastric cancer with peritoneal metastasis
Thiotepa Containing Regimen as Conditioning Chemotherapy for Lymphoma Involving Central Nervous
System Compared With BuCyE (Busulfan, Cyclophosphamide and Etoposide)
Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence
Phase 2 study of triplet chemotherapy with oxaliplatin, irinotecan and S-1 (OIS) as first-line treatment in patients with advanced biliary tract cancer (BTC)
Prognostic implications of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin
FcrR3A-158 polymorphism and stromal tumor-infiltrating lymphocytes as predictive markers for trastuzumab-based treatment in patients with metastatic HER2-positive breast cancer
Prognostic implications of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma treated with first-line gemcitabine / cisplatin
# 357 Clinical Benefit of Maintenance Therapy for Patients with Advanced Biliary Tract Cancer without
Progression on First-Line Gemcitabine plus Cisplatin
Multiplexed gene expression profiling of resected intrahepatic cholangiocarcinoma: Implication of FGFR4-FGF19 as a novel treatment target
Efficacy and Safety of Targeted agents for Treatment of Gastroenteropancreatic (GEP) Neuroendocrine tumor (NET): Single Center Experience
Efficacy of Chemotherapy in Patients with Pancreatic Acinar Cell Carcinoma
Clinical outcomes of patients with pancreatic neuroendocrine tumors treated with targeted agents: single center experience
Predictive role of stromal tumor infiltrating lymphocytes (TILs) in patients with metastatic HER2-positive breast cancer (BC) treated with trastuzumab
Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in patients with advanced gastric cancer with peritoneal metastasis
Thiotepa Containing Regimen as Conditioning Chemotherapy for Lymphoma Involving Central Nervous
System Compared With BuCyE (Busulfan, Cyclophosphamide and Etoposide)
Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.